Infection Surveillance Solutions Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Infection Surveillance Solutions encompass software platforms, data analytics tools, and consulting services that enable healthcare facilities to monitor infections in real time, automate regulatory reporting, and identify outbreak patterns. These systems process clinical data from electronic health records, laboratory systems, and pharmacy databases to give infection preventionists the visibility needed to intervene before infections spread. The market has matured significantly over the past decade as regulatory bodies have imposed mandatory reporting requirements and healthcare systems recognize the financial and clinical costs of preventable infections.

• •Market valued at approximately $1.1 billion globally in 2025, with projections to reach roughly $2.2 billion by 2030 at a 15.1% CAGR
• •Core customers include acute-care hospitals, long-term care facilities, ambulatory surgery centers, and public health agencies
• •Solutions span real-time surveillance dashboards, automated reporting modules, antibiotic stewardship tools, and outbreak alert systems

The most powerful catalyst for market expansion is regulatory pressure, with agencies such as the U.S. Centers for Disease Control and Prevention, the Centers for Medicare and Medicaid Services, and the Joint Commission requiring facilities to track and publicly report certain infection rates. The financial stakes are high, as CMS reimbursement penalties for hospital-acquired conditions have made infection control a board-level priority for healthcare executives. Additionally, the COVID-19 pandemic exposed critical gaps in infection monitoring infrastructure and accelerated investment in digital surveillance capabilities across both developed and emerging healthcare markets.

• •CMS Hospital-Acquired Condition Reduction Program imposes payment penalties on hospitals with above-average infection rates, creating direct ROI for surveillance investment
• •Post-pandemic awareness of infectious disease threats has elevated infection prevention budgets and spurred government funding for public health infrastructure modernization
• •The global burden of antimicrobial resistance, recognized by the World Health Organization as a leading public health threat, is driving adoption of surveillance tools that support antibiotic stewardship programs

The market is commonly segmented by product type into software platforms, which represent the largest and fastest-growing segment, and professional services including implementation, training, and ongoing support. By deployment model, cloud-based solutions are rapidly outpacing on-premises installations due to their scalability and lower infrastructure requirements. Geographically, North America dominates the market, accounting for roughly half of global revenue, driven by its mature healthcare infrastructure and aggressive regulatory environment. Europe represents the second-largest region, while Asia-Pacific is the fastest-growing geographic segment as countries like China, India, and Japan invest heavily in healthcare digitization.

• •North America holds approximately 45-50% of global market share, supported by mandatory HAI reporting laws and advanced EHR adoption
• •Europe accounts for roughly 25-30% of the market, with strong growth fueled by EU-wide patient safety directives and national infection control mandates
• •Asia-Pacific is projected to grow at the highest regional rate, with expanding hospital capacity and government initiatives to strengthen infectious disease surveillance systems

What are the recent trends and outlook?

Artificial intelligence and machine learning are rapidly transforming infection surveillance by enabling predictive analytics that can forecast outbreak risks before infections occur, shifting the discipline from reactive reporting to proactive prevention. Integration with Internet of Things devices and real-time location systems is allowing hospitals to monitor environmental contamination, staff movement, and equipment usage as part of holistic infection prevention strategies. Over the next five years, the market is expected to consolidate modestly as larger health technology companies acquire specialized vendors, while interoperability standards and data-sharing initiatives will expand the scope of surveillance beyond individual facilities to regional and national public health networks.

• •AI-driven predictive surveillance tools that analyze patterns across multiple data sources are moving from pilot programs to mainstream adoption in large health systems
• •Expansion of National Healthcare Safety Network reporting requirements in the United States and similar frameworks in other countries will broaden the addressable market
• •Growing emphasis on One Health approaches that track infections across human, animal, and environmental domains is creating new demand for cross-sector surveillance platforms